Latest News
Anavex Life Sciences Corp.
- Anavex Life Sciences Corp. Estimates – TRADEGATE:12X1
- Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies
- Form 8K Anavex Life Sciences Corp For: 20 October By Investing.com
- Anavex completes drug studies for Alzheimer’s treatment candidate By Investing.com
- Anavex: Downgrading To Sell On Blarcamesine MAA Withdrawal For AD, Pipeline Change (AVXL)
- Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome
- Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Deadline Alert: Anavex Life Sciences Corp. (AVXL) Shareholders Wh
- Class action lawsuit filed against Anavex Life Sciences over alleged false statements and regulatory issues.
- Form 4 Anavex Life Sciences Corp For: 28 September By Investing.com
- Anavex Life Sciences board election triggers change in control and full vesting of awards
- Rosen Law Firm Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation - AVXL
Headlines from the last 30 days, linking to the original publishers. See all market news →